Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the DNA And Gene Chip Market from 2024 to 2025?

The market size for DNA and gene chips has seen substantial expansion in the past few years. Expansion is expected to continue from $8.19 billion in 2024 to $9.27 billion in 2025, representing a compound annual growth rate (CAGR) of 13.1%. Factors like advancements in genomic research, the emergence of personalized medicine, achievements in the human genome project, progress in drug discovery, and identification of disease biomarkers have contributed to its growth in the historical period.

What Is the Projected Market Size of the DNA And Gene Chip Market?

In the coming years, the DNA and gene chip market is predicted to witness substantial expansion. It is forecasted to escalate to a value of $15.35 billion by 2029, boasting a compound annual growth rate (CAGR) of 13.4%. The growth over the forecast period is likely due to the progress in precision medicine, the enlargement of biomarker discovery, increase in personalized therapeutics, its utilization in cancer research, and the amplification of research funding. The forecast period will also see leading trends, including technological advancements, creative product innovations, adherence to regulatory framework and compliance, a focus on the study of rare diseases, and a constant decline in costs.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp

Who are the Major Competitors in the DNA And Gene Chip Market Outlook?

Major companies operating in the DNA and gene chip market are PerkinElmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies Inc., Greiner Bio-One International GmbH, CapitalBio Corporation, Microarrays Inc., bioMérieux SA, Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, Eurofins MWG Operon LLC, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Cepheid, Eppendorf AG, Fluidigm Corporation, GE Healthcare, Genisphere LLC, Gyros Protein Technologies AB, Hitachi High-Technologies Corporation, LC Sciences

What Is Fueling Growth in the DNA And Gene Chip Market?

The surge in need for early diagnosis of cancer is playing a pivotal role in boosting the growth of the DNA and gene market. Cancer encompasses a wide range of conditions that occur in virtually any organ or tissue when rogue cells grow uncontrollably, breaking normal cellular boundaries to invade neighbouring organs and spread to different parts of the body. DNA and gene chips come into play in the measurement of gene expression patterns, determination of genetic and epigenetic scenery, and gauging genomic regulatory elements bound by cancer transcription factors in cancer-inflicted cells. For instance, as per the estimates of the American Cancer Society, a community-based voluntary health organization in the US, around 1.9 million new cases of cancer are expected to be diagnosed and approximately 609,360 cancer-related deaths are anticipated in the United States in 2022. Consequently, the escalating need for early diagnosis of cancer is propelling the expansion of the DNA and gene chip market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8205&type=smp

Which DNA And Gene Chip Market Segments Are Growing the Fastest?

The DNA and gene chip market covered in this report is segmented –

1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types

2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications

3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users

Subsegments:

1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips, Commercial Oligonucleotide Arrays

2) By Complementary DNA (c-DNA): cDNA Microarrays, cDNA Expression Arrays

3) By Other Types: Single-Cell RNA Sequencing Chips, SNP (Single Nucleotide Polymorphism) Chips, Whole Genome Amplification Chips

Which Industry Trends Are Shaping the Future of the DNA And Gene Chip Market?

The DNA and gene chip market is witnessing a rising trend of strategic alliances and collaborations. Numerous market players are seeking partnerships to bolster their market standing. For instance, in June 2022, the India-based systems biology platform company, Avesthagen Limited, initiated a four-year strategic alliance with the India-based IT firm, Wipro Limited. This collaboration is targeted at a project titled “Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA” for genomics sequencing services linked to lung cancer. In another instance, Thermo Fisher Scientific, a US-based analytical instruments supplier, teamed up with Qatar Genome Program (QGP), a subsidiary of Qatar Foundation (QF), in May 2022. Aimed at creating an Axiom custom genotyping array for pan-Arab populations, the partners are using whole genome sequencing data from 19 Arab nations. The array, featuring 800,000 variants, strives to amplify genomic research emphasizing conditions like diabetes, cardiovascular disorders, autism and cancer. This joint effort is in line with Qatar’s national vision for boosting population health and facilitating the progress of precision medicine for individuals of Arab descent globally. Thermo Fisher’s Axiom microarray technology is instrumental in expediting precision medicine initiatives.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

Which Countries Are Leading the DNA And Gene Chip Market?

North America was the largest region in the DNA and gene chip market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8205

This Report Delivers Insight On:

1. How big is the dna and gene chip market, and how is it changing globally?

2. Who are the major companies in the dna and gene chip market, and how are they performing?

3. What are the key opportunities and risks in the dna and gene chip market right now?

4. Which products or customer segments are growing the most in the dna and gene chip market?

5. What factors are helping or slowing down the growth of the dna and gene chip market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model